ArticleMedicine2019

A novel etanercept biosimilar Anbainuo plus methotrexate exhibits increased cost-effectiveness compared to conventional disease-modifying anti-rheumatic drugs in treating rheumatoid arthritis patients.

Feng Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.